Immunosuppression in Transplantation
- 1 September 2000
- journal article
- Published by Elsevier in Critical Care Nursing Clinics of North America
- Vol. 12 (3) , 315-321
- https://doi.org/10.1016/s0899-5885(18)30097-2
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- CLINICAL APPLICATION OF IMMUNOSUPPRESSIVE AGENTS IN RENAL TRANSPLANTATIONSurgical Clinics of North America, 1998
- TransplantationJournal of the American College of Surgeons, 1998
- IMMUNOSUPPRESSIVE THERAPY IN HIGH-RISK TRANSPLANT PATIENTSTransplantation, 1997
- Tacrolimus: a new immunosuppressive agentAmerican Journal of Health-System Pharmacy, 1995
- Comparative evaluation of tacrolimus (Fk506) and cyclosporin a as immunosuppressive agentsTransplantation Reviews, 1995
- RAPAMYCIN BUT NOT FK506 INHIBITS THE PROLIFERATION OF MONONUCLEAR PHAGOCYTES INDUCED BY COLONY-STIMULATING FACTORSTransplantation, 1994
- RAPAMYCIN INHIBITS ARTERIAL INTIMAL THICKENING CAUSED BY BOTH ALLOIMMUNE AND MECHANICAL INJURYTransplantation, 1993
- EFFECT OF A SHORT COURSE OF RAPAMYCIN, CYCLOSPORIN A, AND DONOR-SPECIFIC TRANSFUSION ON RAT CARDIAC ALLOGRAFT SURVIVALTransplantation, 1993
- Clinical trial of FK 506 immunosuppression in adult cardiac transplantationThe Annals of Thoracic Surgery, 1992
- Renal TransplantationCritical Care Nursing Clinics of North America, 1992